GeoVax Labs Company Profile (OTCMKTS:GOVX)

About GeoVax Labs

GeoVax Labs logoGeoVax Labs, Inc. (GeoVax) is a clinical-stage biotechnology company. The Company is engaged in developing human vaccines against infectious diseases using its modified vaccine Ankara-virus-like particles (MVA-VLP) vaccine platform. The Company's platform supports in vivo expression of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine. The Company's development programs are focused on vaccines against Human Immunodeficiency Virus (HIV), Zika virus and hemorrhagic fever viruses (Ebola, Marburg and Lassa Fever), as well as for use in cancer immunotherapy. The Company's clinically advanced vaccine development program is a (deoxyribonucleic acid (DNA)/MVA) vaccine regimen designed to protect against the clade B subtype of the HIV virus. The Company is developing a Tetravalent Vaccine (TV) utilizing its MVA-VLP platform to address the unmet need for a product that can respond to future filovirus epidemics.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: GOVX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.08
  • 50 Day Moving Average: $0.08
  • 200 Day Moving Average: $0.08
  • 52-Week Range: $43,715,000.00 - $0.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.33
  • P/E Growth: 0.00
  • Market Cap: $3.50M
  • Outstanding Shares: 43,715,000
  • Beta: 0.23
Profitability:
  • Net Margins: -681.80%
  • Return on Equity: -660.10%
  • Return on Assets: -286.85%
Debt:
  • Current Ratio: 1.39%
  • Quick Ratio: 1.39%
Additional Links:
Companies Related to GeoVax Labs:

Analyst Ratings

Consensus Ratings for GeoVax Labs (OTCMKTS:GOVX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for GeoVax Labs (OTCMKTS:GOVX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for GeoVax Labs (OTCMKTS:GOVX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
11/19/2014($0.03)($0.02)ViewN/AView Earnings Details
8/22/2014($0.03)($0.03)ViewN/AView Earnings Details
5/2/2014($0.03)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GeoVax Labs (OTCMKTS:GOVX)
Current Year EPS Consensus Estimate: $-0.09 EPS
Next Year EPS Consensus Estimate: $-0.06 EPS

Dividends

Dividend History for GeoVax Labs (OTCMKTS:GOVX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GeoVax Labs (OTCMKTS:GOVX)
Insider Ownership Percentage: 7.60%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2015Randal D ChaseDirectorBuy10,000$0.19$1,900.00View SEC Filing  
4/23/2015Mark ReynoldsCFOBuy30,000$0.17$5,100.00View SEC Filing  
4/20/2015Randal D ChaseDirectorBuy30,000$0.17$5,100.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GeoVax Labs (OTCMKTS:GOVX)
DateHeadline
finance.yahoo.com logoGOVX: Progress Made to Advance its Vaccine Programs (OTCMKTS:GOVX)
finance.yahoo.com - August 29 at 5:11 PM
finance.yahoo.com logoGeoVax Reports 2016 Second Quarter Financial Results and Provides Corporate Update (OTCMKTS:GOVX)
finance.yahoo.com - August 5 at 5:24 PM
publicnow.com logoGeoVax Awarded NIH Contract for up to $7.8 Million to Manufacture HIV Vaccine for Advanced Human Clinical Trials (OTCMKTS:GOVX)
www.publicnow.com - August 2 at 5:32 PM
publicnow.com logoGeoVax Reports Progress with Hemorrhagic Fever Vaccine Program (OTCMKTS:GOVX)
www.publicnow.com - July 27 at 9:28 AM
finance.yahoo.com logoUPDATE - GeoVax Announces Filing of Investigational New Drug Application for HIV Human Clinical Trial (OTCMKTS:GOVX)
finance.yahoo.com - July 1 at 9:00 AM
publicnow.com logoGeoVax Announces Filing of Investigational New Drug Application for HIV Human Clinical Trial (OTCMKTS:GOVX)
www.publicnow.com - June 30 at 10:01 AM
publicnow.com logoGeoVax Announces Filing of Investigational New Drug Application for HIV Human Clinical Trial (OTCMKTS:GOVX)
www.publicnow.com - June 30 at 10:01 AM
finance.yahoo.com logo9:01 am GeoVax announces VNIH filed an INDA w/ the FDA for the conduct of the next human clinical trial of its preventive HIV vaccine (OTCMKTS:GOVX)
finance.yahoo.com - June 30 at 9:01 AM
finance.yahoo.com logo9:01 am GeoVax announces VNIH filed an INDA w/ the FDA for the conduct of the next human clinical trial of its preventive HIV vaccine (OTCMKTS:GOVX)
finance.yahoo.com - June 30 at 9:01 AM
publicnow.com logoGeoVax Awarded NIH Grant for HIV Vaccine Program (OTCMKTS:GOVX)
www.publicnow.com - June 29 at 9:51 AM
4-traders.com logoGeovax Labs : Discusses Zika Vaccine Development at American Society for Virology’s 35th Annual Meeting (OTCMKTS:GOVX)
www.4-traders.com - June 22 at 9:56 AM
publicnow.com logoGeoVax Discusses Zika Vaccine Development at American Society for Virology’s 35th Annual Meeting (OTCMKTS:GOVX)
www.publicnow.com - June 21 at 3:29 PM
finance.yahoo.com logoGeoVax Discusses Zika Vaccine Development at American Society for Virology's 35th Annual Meeting (OTCMKTS:GOVX)
finance.yahoo.com - June 21 at 2:30 PM
biz.yahoo.com logoGEOVAX LABS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of (OTCMKTS:GOVX)
biz.yahoo.com - June 16 at 10:10 AM
publicnow.com logoGeoVax to Discuss Zika Vaccine Development Progress at American Society for Virology Meeting (OTCMKTS:GOVX)
www.publicnow.com - June 13 at 1:39 PM
finance.yahoo.com logoGOVX: GeoVax: Entering into HBV Market (OTCMKTS:GOVX)
finance.yahoo.com - June 7 at 11:15 AM
publicnow.com logoGeoVax Developing Vaccine to Treat Chronic Hepatitis B Infection (OTCMKTS:GOVX)
www.publicnow.com - June 6 at 9:08 AM
publicnow.com logoGeoVax Ebola Vaccine Protects Non-Human Primates Against Lethal Challenge (OTCMKTS:GOVX)
www.publicnow.com - June 1 at 10:03 AM
finance.yahoo.com logoGOVX: Update on First Quarter Financials (OTCMKTS:GOVX)
finance.yahoo.com - June 1 at 10:00 AM
finanznachrichten.de logoGeoVax Recognizes National Black HIV/AIDS Awareness Day / Bringing Attention to Minority Health Disparities in HIV/AIDS and the Need for a Vaccine (OTCMKTS:GOVX)
www.finanznachrichten.de - February 5 at 2:10 PM
nasdaq.com logoIndian Pharma Files For Patent For First Zika Vaccine (OTCMKTS:GOVX)
www.nasdaq.com - February 3 at 1:38 PM

Social

GeoVax Labs (OTCMKTS:GOVX) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff